Skip to main content

Newsroom

Latest News

December 14, 2016

The Cures Act, formally known as H.R. 34 or the 21st Century Cures Act,1 passed overwhelmingly in the U.S. House of Representatives and Senate in the waning days of the 114th Congress and was signed into law by President Barack Obama on December 13, 2016. Weighing in at nearly 1000 pages, this bipartisan bill is the product of years of hard work by Republican and Democratic lawmakers, in collaboration with a broad array of diverse stakeholders.

December 13, 2016

Congratulations are due to Congresswoman Diana DeGette and a bipartisan team of lawmakers who managed what seems increasingly difficult in these days of hyper-partisanship and Washington gridlock: passage of a major bill full of promise for the American people.

President Barack Obama is expected to sign the 21st Century Cures Act, which received massive support in both the House and Senate in recent days, after years of work on the part of DeGette, the Denver Democrat, and Republican Congressman Fred Upton of Michigan.

December 13, 2016

President Obama has just signed the 21st Century Cures Act into law. This landmark legislation makes significant investments in biomedical research. It will lead to new treatments for some of the most vexing medical challenges, including diseases that touch many Americans, such as Alzheimer’s and cancer.

December 9, 2016

WASHINGTON — With self-congratulatory zeal and smiles all around, huge bipartisan majorities in Congress have just passed legislation to speed the discovery of cures for killer diseases. At the same time, Republican leaders have been devising a strategy to undo the Affordable Care Act, which has done more than any law in a generation to treat people with those diseases.

“It is a real contradiction,” said Dr. Otis W. Brawley, the chief medical officer at the American Cancer Society.

December 8, 2016

Washington, DC Congresswoman Diana DeGette (D-CO) today hailed the decision by the U.S. Department of Housing and Urban Development to provide a $30 million grant that she helped secure for affordable housing and neighborhood revitalization in Denver.

December 6, 2016

Thank you, Mr. Chairman.

This is the last EPA hearing this Committee will hold with the Obama Administration.

The EPA has not always received the support it deserves from Congress. Even as the Agency has worked to fulfill its mission of protecting human health and the environment, it has faced criticism and attack.

Despite sometimes unfair opposition, EPA has commendably responded to unprecedented environmental challenges facing the country and the planet. I would like to highlight some of the agency’s accomplishments. Under the Obama Administration:

December 3, 2016

With passage in the House of Representatives of the 21st Century Cures Act that I co-authored with Michigan Republican Rep. Fred Upton, we’re just two steps away from a major victory for U.S. research into causes and treatments for disease. The next few days will decide its fate as the U.S. Senate prepares to vote.

More than 700 groups representing patients, health care providers, researchers and others have voiced support for the bill – as has the White House, which provided its enthusiastic endorsement before and just after the House approved it by a vote of 392 to 26.

December 2, 2016

WASHINGTON — The House overwhelmingly passed a far-reaching measure on Wednesday to increase funding for research into cancer and other diseases, address weaknesses in the nation’s mental health systems and help combat the prescription drug addictions that have bedeviled nearly every state.

The bill, known as the 21st Century Cures Act, also makes regulatory changes for drugs and medical devices, which critics argue lower standards to potentially perilous levels.

December 2, 2016

In the coming days, the Republican-controlled Congress is likely to approve legislation that will invest more than $6 billion in public health and medical research over the next decade. It will expedite basic research into new medical devices and disease-curing drugs. It will reform mental health treatment and fund research into brain injuries and Alzheimer’s. The bill authorizes $1 billion to combat the opioid epidemic and $1.8 billion for Vice President Joe Biden’s “moonshot” project to cure cancer.

December 2, 2016

WASHINGTON — A bill that would make sweeping changes to the medical research field passed the U.S. House on Wednesday, getting U.S. Rep. Diana DeGette of Denver that much closer to securing a win for her top legislative priority.

The 392-26 vote was a larger margin than the 344-77 vote that backed a 2015 version of the bill, but came as some Senate Democrats and progressive groups raised concerns over whether the measure does too much to help drug and medical-device companies.